{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:50:12Z","timestamp":1778629812146,"version":"3.51.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2010,4,15]],"date-time":"2010-04-15T00:00:00Z","timestamp":1271289600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00417-010-1375-0","type":"journal-article","created":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T07:29:55Z","timestamp":1271230195000},"page":"1257-1262","source":"Crossref","is-referenced-by-count":54,"title":["Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels"],"prefix":"10.1007","volume":"248","author":[{"given":"Joo Yong","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Byung","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Jae","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Hee","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"June-Gone","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,15]]},"reference":[{"key":"1375_CR1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.preteyeres.2003.08.001","volume":"22","author":"A Das","year":"2003","unstructured":"Das A, McGuire PG (2003) Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition. Prog Retin Eye Res 22:721\u2013748","journal-title":"Prog Retin Eye Res"},{"key":"1375_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1350-9462(02)00043-5","volume":"22","author":"AN Witmer","year":"2003","unstructured":"Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO (2003) Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 22:1\u201329","journal-title":"Prog Retin Eye Res"},{"key":"1375_CR3","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.ophtha.2005.03.002","volume":"112","author":"ME Hartnett","year":"2005","unstructured":"Hartnett ME, McColm JR (2005) Diode laser for ROP. Ophthalmology 112:1636, author reply 1636","journal-title":"Ophthalmology"},{"key":"1375_CR4","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s00417-007-0661-y","volume":"245","author":"EJ Chung","year":"2007","unstructured":"Chung EJ, Kim JH, Ahn HS, Koh HJ (2007) Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 245:1727\u20131730","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1375_CR5","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-008-0786-7","volume":"246","author":"S Honda","year":"2008","unstructured":"Honda S, Hirabayashi H, Tsukahara Y, Negi A (2008) Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 246:1061\u20131063","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1375_CR6","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/IAE.0b013e3181644ad2","volume":"28","author":"GA Lalwani","year":"2008","unstructured":"Lalwani GA, Berrocal AM, Murray TG, Buch M, Cardone S, Hess D, Johnson RA, Puliafito CA (2008) Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina 28:S13\u2013S18","journal-title":"Retina"},{"key":"1375_CR7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IAE.0b013e318177f934","volume":"28","author":"HA Mintz-Hittner","year":"2008","unstructured":"Mintz-Hittner HA, Kuffel RR Jr (2008) Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 28:831\u2013838","journal-title":"Retina"},{"key":"1375_CR8","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/IAE.0b013e318159ec6b","volume":"28","author":"H Quiroz-Mercado","year":"2008","unstructured":"Quiroz-Mercado H, Martinez-Castellanos MA, Hernandez-Rojas ML, Salazar-Teran N, Chan RV (2008) Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity. Retina 28:S19\u2013S25","journal-title":"Retina"},{"key":"1375_CR9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1136\/bjo.2006.095190","volume":"90","author":"MS Spitzer","year":"2006","unstructured":"Spitzer MS, Wallenfels-Thilo B, Sierra A, Yoeruek E, Peters S, Henke-Fahle S, Bartz-Schmidt KU, Szurman P (2006) Antiproliferative and cytotoxic properties of bevacizumab on different ocular cells. Br J Ophthalmol 90:1316\u20131321","journal-title":"Br J Ophthalmol"},{"key":"1375_CR10","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1073\/pnas.93.6.2576","volume":"93","author":"B Olofsson","year":"1996","unstructured":"Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V, Saksela O, Orpana A, Pettersson RF, Alitalo K, Eriksson U (1996) Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A 93:2576\u20132581","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1375_CR11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"The International Classification of Retinopathy of Prematurity revisited","year":"2005","unstructured":"The International Classification of Retinopathy of Prematurity revisited (2005) The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 123:991\u2013999","journal-title":"Arch Ophthalmol"},{"key":"1375_CR12","unstructured":"Wu WC, Lai CC, Chen KJ, Chen TL, Wang NK, Hwang YS, Yeung L, Li LM Long-term tolerability and serum concentration of bevacizumab (avastin) when injected in newborn rabbit eyes. Invest Ophthalmol Vis Sci"},{"key":"1375_CR13","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1167\/iovs.08-2584","volume":"49","author":"LE Smith","year":"2008","unstructured":"Smith LE (2008) Through the eyes of a child: understanding retinopathy through ROP. The Friedenwald lecture. Invest Ophthalmol Vis Sci 49:5177\u20135182","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1375_CR14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/00006982-200406000-00006","volume":"24","author":"KH Park","year":"2004","unstructured":"Park KH, Hwang JM, Choi MY, Yu YS, Chung H (2004) Retinal detachment of regressed retinopathy of prematurity in children aged 2 to 15\u00a0years. Retina 24:368\u2013375","journal-title":"Retina"},{"key":"1375_CR15","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/IAE.0b013e31819a98a9","volume":"29","author":"H Hosseini","year":"2009","unstructured":"Hosseini H, Khalili MR, Nowroozizadeh S (2009) Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina 29:562, author reply 562\u2013564","journal-title":"Retina"},{"key":"1375_CR16","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1167\/iovs.08-1780","volume":"49","author":"ME Hartnett","year":"2008","unstructured":"Hartnett ME, Martiniuk D, Byfield G, Geisen P, Zeng G, Bautch VL (2008) Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest Ophthalmol Vis Sci 49:3107\u20133114","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1375_CR17","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","volume":"92","author":"S Kusaka","year":"2008","unstructured":"Kusaka S, Shima C, Wada K, Arahori H, Shimojyo H, Sato T, Fujikado T (2008) Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study. Br J Ophthalmol 92:1450\u20131455","journal-title":"Br J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1375-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-010-1375-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-010-1375-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:40:55Z","timestamp":1559058055000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-010-1375-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,15]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["1375"],"URL":"https:\/\/doi.org\/10.1007\/s00417-010-1375-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,15]]}}}